sialic
acidbind
immunoglobulintyp
lectin
siglec
cell
surfac
receptor
belong
immunoglobulin
ig
superfamili
extracellular
domain
receptor
compris
one
ligandbind
vset
domain
variabl
number
domain
highsequ
similar
variabl
constant
region
antibodi
respect
siglec
mostli
locat
cell
surfac
hematopoiet
cell
except
schwann
cell
epitheli
cell
human
siglec
murin
siglec
identifi
differ
prefer
bind
termin
sialic
acid
sia
glycan
structur
linkagesensit
fashion
arginin
residu
siglec
vset
domain
critic
contact
carboxyl
group
sia
form
salt
bridg
stabil
bind
interact
phylogenet
siglec
famili
member
subdivid
two
group
first
siglec
conserv
among
differ
speci
show
lowsequ
ident
one
anoth
includ
group
compris
socal
relat
siglec
show
low
gene
conserv
possess
higher
degre
sequenc
ident
among
subfamili
member
conserv
siglec
includ
activ
inhibitori
receptor
inhibitori
siglec
contain
immunoreceptorbas
inhibit
motif
itim
intracellular
domain
confer
abil
antagon
immun
signal
pathway
recruit
shp
phosphatas
convers
activ
siglec
aspart
acid
residu
transmembran
domain
associ
immunoreceptorbas
activ
motif
itam
contain
adaptor
dnaxactiv
protein
kda
promot
signal
immun
respons
lastli
possess
function
intracellular
domain
known
signal
directli
rather
play
role
interact
glycan
ubiquit
eukaryot
cell
surfac
via
incorpor
glycoprotein
glycosphingolipid
glycerophosphatid
mammalian
cell
sia
usual
outmost
sugar
residu
oligosaccharid
chain
cell
surfac
serum
glycoconjug
function
recognit
antirecognit
phenomena
rang
regul
complement
activ
control
apposit
varki
like
host
cell
bacteria
also
evolv
complex
biosynthet
pathway
produc
divers
array
carbohydr
form
build
block
capsular
polysaccharid
cp
lipopolysaccharid
lp
lipooligosaccharid
lo
peptidoglycan
special
bacteri
glycan
play
pivot
role
number
biolog
process
particularli
mediat
interact
onset
develop
infecti
diseas
long
known
bacteri
cp
repres
key
virul
factor
encapsul
bacteri
pathogen
protect
immun
clearanc
within
host
bacteri
capsul
interfer
bind
activ
complement
factor
bacteri
surfac
inhibit
convertas
recruit
inhibitori
complement
factor
h
cross
kelli
bacteri
capsul
exert
immun
resist
mechan
usual
contain
sialic
polysial
acid
hyaluron
acid
ha
structur
ident
similar
polysaccharid
found
mammalian
tissu
exemplifi
escherichia
coli
neisseria
meningitidi
type
b
c
group
group
b
streptococcu
steven
et
al
wessel
et
al
foley
wood
dale
et
al
envelop
hostlik
capsular
structur
confer
resist
complementmedi
kill
phagocyt
uptak
neutrophil
macrophag
increas
chanc
bacteri
surviv
dissemin
host
tissu
addit
passiv
mechan
protect
emerg
hypothesi
rais
base
upon
discoveri
inhibitori
member
siglec
protein
famili
immun
cell
research
explor
whether
hostmimick
pathogen
blunt
activ
antimicrobi
respons
via
engag
inhibitori
siglec
use
sia
cp
parallel
studi
ask
host
evolv
better
recogn
destroy
camouflag
pathogen
interplay
particular
sialyl
human
pathogen
group
b
streptococcu
gb
host
immun
respons
serv
good
first
exampl
illustr
role
siglec
bacteri
express
sia
pathogenesi
infect
gb
lead
caus
neonat
pneumonia
sepsi
mening
increasingli
recogn
pathogen
elderli
immunocompromis
adult
popul
heath
schuchat
thigpen
et
al
skoff
et
al
gb
classifi
ten
serotyp
vari
structur
antigen
featur
share
common
presenc
termin
sia
residu
close
resembl
one
present
throughout
abund
surfac
glycocalyx
human
cell
cieslewicz
et
al
sialyl
cp
differ
gb
serotyp
interact
sever
human
siglec
sia
serotypespecif
manner
carlin
et
al
sia
molecular
mimicri
gb
engag
inhibitori
human
receptor
neutrophil
result
reduc
product
reactiv
oxid
speci
ro
neutrophil
extracellular
trap
net
togeth
impair
bactericid
activ
carlin
et
al
recent
gb
sia
engag
human
platelet
suppress
activ
releas
antimicrobi
peptid
amp
shown
contribut
gb
resist
platelet
kill
uchiyama
et
al
corrobor
find
transgen
mice
express
solubl
receptor
act
decoy
prevent
neutrophil
suppress
resist
gb
infect
vivo
saito
et
al
linkag
underli
sugar
chain
well
substitut
certain
carbon
posit
sia
critic
determin
bind
specif
siglec
one
studi
use
isogen
mutant
differ
oacetyl
phenotyp
show
sia
oacetyl
protect
gb
cp
enzymat
remov
microbi
sialidas
produc
commens
microb
occupi
mucos
nich
gb
weiman
et
al
howev
modif
markedli
reduc
gb
bind
human
highli
oacetyl
gb
mutant
less
abl
accomplish
siamedi
neutrophil
suppress
show
reduc
virul
vivo
weiman
et
al
observ
suggest
gb
must
balanc
compet
evolutionari
select
pressur
fine
tune
oacetyl
level
cp
sia
maxim
surviv
advantag
host
role
gb
cp
sia
engag
inhibitori
siglec
context
vivo
infect
first
address
siglec
defici
mice
due
similar
function
cellular
distribut
human
murin
siglec
upon
lower
dose
gb
challeng
intranas
intraven
siglec
defici
mice
show
increas
product
sever
inflammatori
cytokin
reduc
dissemin
pathogen
brain
gb
mening
howev
exagger
inflammatori
mediat
reduc
antiinflammatori
cytokin
product
observ
siglec
defici
mice
highdos
lethal
challeng
gb
chang
et
al
thu
sum
consequ
gb
molecular
mimicri
inhibitori
siglec
engag
like
vari
base
upon
site
stage
magnitud
infect
importantli
addit
siadepend
siglec
engag
certain
gb
strain
use
surfaceanchor
protein
bind
human
anoth
inhibitori
siglec
preferenti
express
macrophag
neutrophil
proteinmedi
engag
increas
bacteri
attach
macrophag
surfac
simultan
paralyz
macrophag
kill
function
lead
net
reduct
phagocytosi
ro
product
net
format
bactericid
activ
carlin
et
al
counteract
inhibitori
siglec
hijack
strategi
bacteri
pathogen
host
sialoadhesin
play
crucial
role
limit
bacteri
dissemin
receptor
uniqu
express
margin
metallophil
subcapsular
sinu
macrophag
recogn
key
sia
epitop
gb
surfac
howev
lack
intracellular
itm
motif
crocker
gordon
crocker
et
al
bind
gb
cp
sia
promot
phagocyt
bactericid
activ
macrophag
vitro
restrict
gb
dissemin
vivo
chang
et
al
loss
express
affect
macrophag
sampl
trap
capabl
also
product
antigb
antibodi
suggest
key
role
optim
antigen
present
subsequ
adapt
immun
respons
sialyl
pathogen
chang
et
al
anoth
evolutionari
adapt
host
defeat
pathogen
siglec
hijack
emerg
activ
siglec
potenti
counteract
inhibitori
siglecmedi
immun
suppress
angata
et
al
discov
possess
nearli
ident
siabind
domain
inhibitori
gene
convers
coupl
itam
motif
bear
adaptor
angata
et
al
thu
repres
pair
receptor
opposit
signal
effect
exampl
neutrophil
amniot
epithelium
proteinexpress
gb
bind
latter
engag
stimul
map
kinas
akt
signal
promot
effici
bacteri
clearanc
notabl
polymorph
present
human
caus
fusion
gene
result
function
delet
express
yamanaka
et
al
genet
survey
polymorph
gb
colon
prematur
deliveri
found
allel
associ
higher
gb
colon
mother
frequent
prematur
birth
infant
gbsposit
pregnanc
ali
et
al
addit
gb
pathogen
escherichia
coli
neisseria
meningitidi
serotyp
b
import
agent
bacteri
mening
infant
children
possess
sialyl
capsul
cp
produc
two
bacteria
resembl
psa
structur
abundantli
express
neuron
glia
cell
develop
central
nervou
system
cn
critic
neuron
develop
function
finn
devi
et
al
rutishaus
humanspecif
show
uniqu
express
pattern
human
microglia
select
bind
prefer
sia
angata
et
al
hayakawa
et
al
engag
endogen
host
psa
exert
protect
effect
inflammationmedi
neurotox
wang
neumann
mimicri
mammalian
psa
e
coli
n
meningitidi
type
b
cp
may
therefor
target
express
microglia
blunt
immun
respons
facilit
neuroinvas
consist
high
rate
mortal
seriou
neurolog
sequela
seen
pathogen
robbin
et
al
kaper
et
al
interestingli
activ
share
sequenc
ident
first
two
iglik
domain
coupl
itamcontain
later
discov
pair
receptor
allow
finetun
immun
respons
cao
et
al
pathogen
e
coli
engag
inhibitori
psa
capsul
inhibit
macrophag
antibacteri
function
contrast
activ
express
macrophag
recogn
epitop
promot
elimin
pathogen
schwarz
et
al
sum
macrophag
engag
gb
protein
e
coli
psa
capsul
illustr
evolutionari
dynam
activ
member
siglec
receptor
pair
may
overrid
immun
suppress
respons
gener
pathogen
mimicri
inhibitori
siglec
member
addit
cp
sialyl
lp
lo
also
promin
bind
target
siglec
exampl
bind
sialyl
lp
n
meningitidi
cell
express
either
siglec
intern
meningococci
siglec
siadepend
manner
jone
et
al
strain
campylobact
jejuni
express
variou
monosialyl
disialyl
lo
sia
residu
respect
perfectli
mimic
host
neural
gangliosid
colon
c
jejuni
strain
possess
sialyl
lo
epidemiolog
associ
higher
risk
develop
postinfecti
autoimmun
neuropathi
term
syndrom
jacob
et
al
willison
et
al
willison
yuki
sever
human
siglec
recogn
particular
sialyl
lo
structur
although
function
consequ
interact
requir
investig
express
natur
killer
nk
cell
monocyt
dendrit
cell
dc
mediat
specif
siadepend
interact
c
jejuni
lo
avril
et
al
c
jejuni
strain
recogn
express
termin
disialyl
residu
mimick
host
epitop
includ
bind
signal
c
jejuni
correl
abil
elicit
antibodi
strain
recogn
particularli
associ
oculomotor
weak
syndrom
socal
millerfish
variant
heikema
et
al
hand
c
jejuni
sia
lo
chain
show
strong
interact
heikema
et
al
facilit
bacteri
uptak
induc
higher
macrophag
product
proinflammatori
cytokin
heikema
et
al
key
role
recognit
sialyl
c
jejuni
lo
confirm
defici
anim
bonemarrowderiv
macrophag
mice
lack
show
greatli
reduc
phagocytosi
sialyl
c
jejuni
coupl
reduc
product
proinflammatori
cytokin
type
interferon
respons
klaa
crocker
sialyl
lo
import
dc
macrophag
activ
well
subsequ
cell
polar
b
cell
activ
remov
sia
c
jejuni
lo
caus
reduc
myeloid
cell
activ
subsequ
b
cell
respons
kuijf
et
al
huizinga
et
al
vari
sialyl
lo
structur
differenti
modul
dcmediat
cell
polar
siglecdepend
manner
wherein
mimic
induc
pronounc
skew
mimic
preferenti
stimul
respons
bax
et
al
observ
suggest
target
distinct
dcexpress
siglec
may
repres
potenti
strategi
manipul
th
cell
differenti
program
forestal
autoimmun
diseas
post
c
jejuni
infect
addit
modul
host
dc
function
via
sialyl
lo
c
jejuni
trigger
product
dc
via
engag
pseudamin
acid
residu
flagella
stephenson
et
al
abund
sia
sialik
c
jejuni
surfac
structur
eg
pseudamin
acid
help
mediat
complic
interact
host
immun
cell
may
impact
c
jejuni
human
diseas
associ
rang
autoimmun
neuropathi
asymptomat
colon
individu
repeat
exposur
campylobact
spp
addit
wellstudi
microorgan
mention
grow
list
bacteri
speci
discov
display
sialoglycoconjug
surfac
pseudomona
aeruginosa
khatua
et
al
klebsiella
pneumonia
lee
et
al
nontyp
haemophilu
influenza
nthi
kalograiaki
et
al
p
aeruginosa
recruit
host
sialoglycoprotein
display
bacteri
surfac
absorb
sia
enhanc
bacteri
surviv
reduc
complement
deposit
engag
inhibitori
suppress
neutrophil
bactericid
machineri
khatua
et
al
k
pneumonia
exhibit
hypermucoviscos
phenotyp
possess
abund
sia
cp
block
pathogen
abil
engag
inhibitori
enhanc
neutrophil
bactericid
activ
lee
et
al
nthi
lo
also
contain
termin
sia
residu
interact
enhanc
inflammatori
cytokin
product
macrophag
correl
copd
exacerb
human
patient
angata
et
al
observ
suggest
sia
molecular
mimicri
mani
medic
import
bacteria
interplay
variou
siglec
affect
infecti
risk
clinic
diseas
manifest
glycosaminoglycan
gag
anoth
famili
complex
carbohydr
ubiquit
present
mammalian
host
cell
surfac
extracellular
matrix
regul
wide
rang
biolog
function
cell
adhes
cell
migrat
tissu
repair
immun
respons
linhardt
toida
anoth
instanc
molecular
mimicri
gag
structur
discov
sever
gramposit
gramneg
bacteri
capsul
wessel
et
al
jann
jann
deang
gag
ha
structur
ident
anim
capsul
group
streptococcu
ga
serv
molecular
camouflag
evad
host
immun
respons
wessel
et
al
dale
et
al
recent
ga
shown
use
ha
capsul
target
neutrophil
therebi
block
net
format
oxid
burst
inhibit
bactericid
function
secundino
et
al
interest
exampl
converg
evolut
two
structur
unrel
carbohydr
sia
gb
ha
ga
target
distinct
epitop
vset
domain
inhibitori
dampen
immun
respons
promot
pathogen
surviv
human
host
secundino
et
al
although
fundament
distinct
sia
molecular
mimicri
strategi
employ
bacteri
pathogen
engag
inhibitori
siglec
immun
evas
sever
line
evid
indic
virus
take
advantag
siasiglec
interact
cell
target
spread
transinfect
human
immunodefici
exploit
siasiglec
axi
facilit
entri
myeloid
cell
transinfect
cell
notabl
possess
uniqu
extend
iglik
extracellular
domain
structur
extend
surfac
glycocalyx
unmask
state
make
ideal
surfac
entri
target
moreov
contrast
infect
cell
myeloid
cell
rel
resist
cytopath
effect
obviou
deplet
myeloid
cell
patient
escap
host
immun
surveil
may
evolv
hijack
cellular
recognit
pathway
benefit
hide
within
infect
macrophag
transinfect
cell
effici
viral
spread
manner
mani
envelop
retrovirus
envelop
glycoprotein
heavili
glycosyl
mutat
remov
nlink
glycan
site
hiv
simian
immunodefici
viru
siv
impair
viru
attach
entri
auwerx
et
al
direct
interact
siglec
first
report
rempel
et
al
express
level
correl
viral
load
proven
bind
siadepend
manner
facilit
infect
permiss
report
cell
line
rempel
et
al
later
proven
serv
viral
ligand
sever
includ
vari
avid
strain
depend
moreov
interact
facilit
viru
infect
macrophag
cell
zou
et
al
varchetta
et
al
matur
dc
mdc
captur
viral
membran
gangliosid
transfer
viru
bystand
cell
via
establish
immunolog
synaps
two
immun
cell
type
host
cellderiv
sialyl
glycosphingolipid
gsl
particl
membran
ligand
mdc
requir
trigger
mdcmediat
transinfect
cell
lymphoid
organ
yu
et
al
izquierdousero
et
al
puryear
et
al
popul
cervic
dc
lamina
propria
ectocervix
endocervix
express
may
particularli
import
ex
vivo
studi
suggest
cell
transinfect
cell
block
addit
antibodi
perezzsolt
et
al
lossoffunct
variant
gene
recent
identifi
exom
aggreg
consortium
genet
databas
present
human
popul
monocyt
isol
individu
specif
variant
complet
lack
express
reduc
hiv
captur
transinfect
phenotyp
ex
vivo
howev
individu
carri
truncat
protein
show
mark
differ
acquisit
aid
outcom
vivo
suggest
indispens
perhap
domin
role
classic
infecti
rout
dissemin
within
infect
individu
martinezpicado
et
al
import
viral
spread
also
confirm
vivo
murin
retrovir
infect
model
murin
leukemia
viru
mlv
recogn
murin
sialyl
gangliosid
erikson
et
al
sewald
et
al
mlv
captur
sinuslin
macrophag
subsequ
transinfect
cell
synapt
contact
directli
demonstr
timelaps
intravit
laser
scan
microscopi
sewald
et
al
viru
captur
effici
mlv
infect
lymph
node
spleen
significantli
reduc
antibodi
well
mice
sewald
et
al
data
confirm
pivot
role
initi
retrovir
captur
suggest
could
repres
therapeut
target
reduc
viral
laden
macrophag
reservoir
prevent
transinfect
howev
murin
model
splenomegalyinduc
retroviru
friend
viru
complex
fvc
infect
macrophag
captur
incom
bloodborn
retrovirus
limit
spread
erythroblast
red
pulp
fvc
manifest
pathogenesi
uchil
et
al
case
fvc
captur
benefici
activ
dc
promot
cytotox
cell
respons
promot
effici
clear
fvcinfect
cell
uchil
et
al
anoth
welldocu
exampl
siglec
exploit
viral
entri
immun
modul
exampl
porcin
reproduct
respiratori
syndrom
viru
prrsv
prrsv
infect
one
econom
devast
diseas
global
pork
industri
prrsv
narrow
cell
tropism
primarili
target
cell
monocytemacrophag
lineag
duan
et
al
two
cellular
protein
identifi
primari
target
prrsv
bind
intern
duan
et
al
vanderheijden
et
al
lesser
extent
sia
prrsv
virion
mediat
viral
attach
infect
alveolar
macrophag
serv
primari
entri
receptor
respons
siadepend
bind
ntermin
vset
domain
delputt
nauwynck
delputt
et
al
neutral
block
prrsv
infect
dosedepend
manner
overexpress
nonpermiss
cell
enhanc
prrsv
cell
attach
intern
duan
et
al
vanderheijden
et
al
subsequ
studi
sia
viral
envelop
structur
protein
heterodim
identifi
bind
target
van
breedam
et
al
interact
prrsv
interfer
macrophag
phagocyt
activ
may
increas
incid
sever
secondari
bacteri
infect
complic
primari
prrsv
diseas
de
baer
et
al
sinc
two
key
receptor
prrsv
entri
intern
porcin
alveolar
macrophag
neutral
two
viral
receptor
explor
potenti
target
control
prrsv
infect
pig
two
recent
report
support
therapeut
concept
neutral
prrsv
infect
porcin
alveolar
macrophag
achiev
addit
solubl
fc
fusion
protein
recombin
adenoviru
exosomedeliv
microrna
specif
target
chen
et
al
zhu
et
al
addit
pig
receiv
recombin
adenovirusdeliv
solubl
plu
reduc
pprsv
viral
load
fecal
viral
emiss
concurr
improv
clinic
score
higher
surviv
rate
contagi
infect
xia
et
al
notabl
vivo
studi
conduct
knockout
pig
found
absenc
express
alter
clinic
cours
histopatholog
prrsv
infect
prather
et
al
impli
potenti
redund
function
prrsv
infect
import
dual
target
potenti
pharmacolog
intervent
although
gener
recogn
key
entri
mediat
prrsv
infect
recent
report
demonstr
certain
prrsv
strain
infect
cell
exploit
presenc
fryda
nauwynck
xie
et
al
show
higher
affin
type
prrsv
vs
type
prrsv
mediat
attach
endocytosi
prrsv
siadepend
manner
transfect
nonpermiss
cell
also
restor
prrsv
infect
find
indic
prrsv
use
sever
siglec
enter
macrophag
may
influenc
strain
differ
pathogenesi
xie
et
al
note
prrsv
lung
infect
induc
minim
product
type
interferon
inflammatori
cytokin
compar
infect
caus
swine
influenza
viru
porcin
respiratori
coronaviru
van
reeth
et
al
like
inhibitori
siglec
porcin
contain
one
itim
one
itimlik
motif
possibl
like
counteract
key
immun
activ
pathway
induc
viral
infect
crocker
et
al
bud
gslenrich
domain
conserv
featur
envelop
virus
incorpor
host
gsl
viral
envelop
found
hendra
nipah
virus
two
envelop
rna
virus
famili
paramyxovirida
virus
util
axi
potenti
mdcdepend
captur
transinfect
cell
akiyama
et
al
ebola
virus
caus
lethal
hemorrhag
fever
human
mani
recent
outbreak
african
contin
recent
ebola
viru
entri
activ
dc
shown
involv
recognit
sialyl
gangliosid
anchor
ebola
viru
membran
perezzsolt
et
al
blockad
specif
monoclon
antibodi
interrupt
ebola
viral
uptak
cytoplasm
entri
provid
crossprotect
gslcontain
virus
includ
perezzsolt
et
al
find
suggest
incorpor
gsl
viru
particl
membran
facilit
bind
mdc
may
conserv
mechan
envelop
rna
virus
exploit
mdc
system
viru
dissemin
final
modul
cellmedi
antivir
respons
human
respiratori
syncyti
viru
rsv
infect
key
differ
newborn
adult
upon
rsv
infect
express
upregul
monocyt
newborn
adult
wherea
express
ligand
highli
upregul
adult
cell
van
den
berg
et
al
jan
et
al
find
consist
observ
inhibit
product
adult
cell
newborn
cell
although
detail
mechan
remain
unknown
jan
et
al
unlik
mani
bacteri
viral
infect
parasit
diseas
caus
protozoa
helminth
often
chronic
last
month
year
even
lifetim
anim
parasit
develop
remark
strategi
interfer
avoid
immun
clearanc
mechan
establish
chronic
infect
vertebr
host
includ
sever
exampl
siasiglecmedi
interact
help
achiev
immun
evas
phenotyp
protozoan
parasit
trypanosoma
cruzi
caus
agent
chaga
diseas
illustr
well
sia
exploit
anim
parasit
escap
host
immun
surveil
first
encount
innat
immun
cell
latemount
adapt
immun
respons
although
cruzi
synthes
sia
de
novo
use
transsialidas
tct
enzym
transfer
sia
host
sialylglycoconjug
surfac
mucin
pereira
pereira
et
al
highli
sialyl
mucinlik
coat
gener
cruzi
surfac
confer
resist
complementmedi
kill
imped
convertas
assembl
block
potenti
lytic
effect
host
antibodi
would
recogn
otherwis
expos
epitop
mucinlik
glycoprotein
pereirachioccola
et
al
tomlinson
et
al
moreov
cruzi
sialylglycoconjug
facilit
bind
host
macrophag
interact
may
involv
initi
trypomastigot
infect
monteiro
et
al
cruzi
also
use
surfac
sialylglycoconjug
engag
siglec
dc
activ
suppress
product
proinflammatori
cytokin
impair
gener
protect
respons
erdmann
et
al
presenc
link
sialoglycan
also
discov
anoth
flagel
protozoa
leishmania
donovani
caus
organ
indian
viscer
leishmaniasi
chatterje
et
al
high
siacontain
virul
strain
bind
interact
promot
macrophag
uptak
parasit
promot
dissemin
site
within
bodi
wherea
bind
suppress
ro
cytokin
respons
infect
macrophag
counteract
mapk
signal
pathway
roy
mandal
lastli
vagin
caus
fungal
pathogen
candida
common
frequent
recurr
condit
women
health
recent
combin
global
genet
immun
profil
studi
clinic
popul
identifi
polymorph
candid
genet
predisposit
involv
candida
vagin
suscept
jaeger
et
al
particular
polymorph
associ
great
inflammasom
signal
product
respons
candida
vitro
vivo
silenc
murin
vagin
model
associ
increas
fungal
burden
neutrophil
inflamm
jaeger
et
al
recent
evid
indic
siglec
function
intersect
host
innat
immun
sens
pathway
modul
respons
viral
bacteri
infect
import
way
exampl
rna
viru
vesicular
stomat
viru
vsv
upregul
siglecg
express
macrophag
intracellular
nucleic
acid
sensor
rigi
mechan
chen
et
al
subsequ
recruit
phosphatas
siglecg
intracellular
domain
initi
pathway
rigi
degrad
thu
suppress
antivir
immun
corrobor
inactiv
siglecg
protect
mice
lethal
vsv
infect
chen
et
al
vsv
infect
also
result
upregul
macrophag
trigger
neg
regul
pathway
degrad
via
ubiquitin
ligas
suppress
type
interferon
product
allow
viru
escap
immun
elimin
zheng
et
al
siglecg
express
low
dc
siglecg
defici
mice
gener
antigenspecif
cytotox
cell
respons
inhibit
intracellular
bacteri
infect
ding
et
al
one
line
evid
develop
recent
year
suggest
potenti
direct
interact
siglec
receptor
eg
human
murin
siglec
f
variou
tolllik
receptor
tlr
downregul
inflammatori
pathway
downstream
pattern
recognit
chen
et
al
consequ
siglec
delet
seen
boost
dc
respons
broad
rang
microbi
tlr
ligand
model
activ
mammalian
sialidas
cell
surfac
disrupt
interact
suggest
serv
derepress
allow
posit
feedback
tlr
activ
infect
chen
et
al
caution
warrant
howev
anoth
studi
appli
quantit
proteom
three
differ
strain
siglecedefici
mice
quantit
proteom
found
consist
differ
signal
endocytosi
respons
lp
macrophag
siglecedefici
mice
exhibit
signific
differ
uptak
kill
salmonella
enterica
vitro
nagala
et
al
siglec
import
broadli
distribut
lectin
receptor
leukocyt
uniqu
pois
detect
sia
perturb
homeostasi
diseas
state
import
siglec
immunopatholog
propos
earli
identif
biolog
marker
myeloid
leukemia
b
cell
lymphoma
respect
mount
evid
support
concept
sia
molecular
mimicri
serv
virul
mechan
subvert
host
innat
immun
infect
permiss
target
cell
interplay
variou
siglec
understand
siglec
influenc
glycansmedi
interact
rapidli
expand
deepen
consider
interest
exploit
siglec
immunotherapi
diseas
prevent
design
glycanbas
therapeut
requir
potenc
specif
like
provid
new
biotechnolog
approach
effect
interven
immunolog
process
reduc
incid
sever
infecti
diseas
